SRPT
Sarepta Therapeutics Inc
17.50$
-0.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -573.2% | – | -733.9% | – | -105.6% | – | -254.5% | – | – | |
| – | +4.1% | -23.1% | -0.3% | +12.5% | +6.6% | -4.6% | +8.6% | +70.2% | -71.5% | +101.7% | +98.3% | – | |
| – | -4.7% | -11.2% | +24.1% | -13.9% | +14.3% | -16.6% | -10.6% | -59.7% | +101.1% | -2.1% | +83.2% | – | |
| – | – | – | – | – | – | – | – | -159.0% | – | -272.7% | – | – | |
| – | -53.3% | +122.9% | -31.3% | +27.8% | +2.2% | +20.5% | -30.3% | -11.7% | -79.4% | -47.1% | -14.4% | – | |
| – | -69.4% | – | -145.0% | +30.7% | – | -138.1% | – | +621.5% | -58.6% | -239.7% | +69.5% | – | |
| – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | -90.5% | +40,670.1% | -71.7% | -100.0% | – | – | |
| – | -87.4% | +1,039.5% | +80.3% | -65.5% | +256.1% | -74.5% | -291.0% | +394.6% | -66.7% | – | +0.0% | – | |
| – | – | – | – | – | – | -195.2% | – | -62.9% | +88.2% | -279.0% | – | – | |
| – | – | – | – | – | – | -1,266.2% | – | -118.7% | – | -264.1% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.